BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

VB Spine Expands Globally with Acquisition of Stryker’s Spinal Implants Business in Australia and New Zealand

Stryker’s spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor...

August 01, 2025 | News

Quanterix Launches First-to-Market p‑Tau 205 and 212 Assays, Expanding Alzheimer’s Biomarker Portfolio

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, announced the first to market, com...

August 01, 2025 | News

Leo Cancer Care’s Marie® Secures FDA 510(k) Clearance, Pioneering Upright Particle Therapy in the U.S.

Leo Cancer Care, a leader in upright radiotherapy solutions, announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. F...

July 31, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)

Johor’s Healthcare & Life Sciences Investment Boom (2022–2025) Over the past three years, the southern Malaysian state of Johor has emerge...

July 30, 2025 | Report

Suzhou’s Kintor Pharma Reports Positive Phase II Results for KX-826 in AGA Trial, Clears Path for Phase III

Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and po...

July 28, 2025 | News

Revival Healthcare Capital and Olympus Launch $458M Joint Venture to Advance GI Robotics Innovation

Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a st...

July 28, 2025 | News

Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...

July 28, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

July 25, 2025 | News

Precision Medicine – Are We Ready for It?

Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...

July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India

Community Health Systems to Sell Ambulatory Lab Services to Labcorp for $195 Million in Multi-State Deal

Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a defi...

July 23, 2025 | News

Smart Implants and the Future of Musculoskeletal Injury Treatment

While these methods are structurally effective, they cannot adapt to each patient's recovery process or provide insight into the progression of healing. Th...

July 21, 2025 | News

Amarna Therapeutics and NorthX Biologics Advance Nimvec™ AM510 Toward Clinical Trials for Type 1 Diabetes

Fast-Tracking Clinical Readiness: The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 ...

July 14, 2025 | News

CEL-SCI Aligns with Saudi Pharma Leader to Fast-Track Multikine Access Under Breakthrough Medicine Designation

Strong interest from Saudi investment funds in CEL-SCI, Multikine, and potential joint venture to address the wider Middle East and North Africa market ...

July 14, 2025 | News

Stay Connected